How CyberKnife Tracks a Moving Tumor: Robotic Arm, Real-Time Imaging and Breathing

The first thing many people notice in the treatment room is how quiet it is. No spinning gantry, no clamp bolted to the skull, just a slender white arm the size of a factory robot, pausing, tilting, and moving on. Then the question that brought them there surfaces: the tumor is in my lung, and I cannot stop breathing for forty minutes. How can anything hit a target that never stays still?

That question is really about engineering as much as medicine. Understanding how does CyberKnife track tumor movement means understanding three things working together: a robotic arm that can approach from hundreds of angles, a pair of X-ray cameras that keep checking where the target actually is, and a breathing model that predicts where it will be a fraction of a second from now.

What follows is a plain-language tour of that machinery, written for the person lying on the couch rather than the physicist behind the glass, with an honest account of what it can and cannot do.

How does CyberKnife track tumor movement? The short version

CyberKnife is the brand name of one type of stereotactic radiosurgery system. Stereotactic radiosurgery, often shortened to SRS, is a way of giving a high dose of focused radiation to a small target in one to five sessions, without a scalpel, using many narrow beams that converge on the tumor while the surrounding tissue receives far less.

What sets this particular design apart is the way it handles motion. Older approaches dealt with a moving target by treating a bigger box around it, on the theory that if you irradiate everywhere the tumor might go, you will not miss. That works, but it costs healthy tissue. The robotic approach turns the idea around: shrink the box, and move the beam instead.

Three systems make that possible. A compact linear accelerator, the machine that generates the therapeutic X-rays, sits on the end of a six-jointed robotic arm. Two diagnostic X-ray sources are mounted in the ceiling with detectors in the floor, so at intervals during treatment they take a pair of images from different angles. Software then compares those images with the digitally reconstructed pictures created from the planning CT scan. If the target has shifted, the arm re-aims before the next beam.

For tumors that ride up and down with the breath, a fourth layer joins in. Small light-emitting markers on a vest track the chest wall continuously, and the system learns the relationship between chest motion and tumor position so it can follow the tumor between X-ray images rather than waiting for the next picture.

The rest of this article unpacks each of those pieces. The important point to hold on to is that nothing here is magic: the accuracy comes from repeated measurement, a mathematical model, and a treatment plan built carefully in advance by a team of radiation oncologists, physicists and therapists.

Why tumors move in the first place

A brain tumor, sealed inside the skull, barely moves at all. Aim at the bone and you have effectively aimed at the tumor. Below the neck, life gets more complicated.

Breathing is the biggest culprit. The diaphragm, the sheet of muscle under the lungs, drops with every inhale and pulls the lungs, liver, pancreas and kidneys down with it. A tumor near the top of the lung may shift only a little; one sitting low in the lung or in the liver can travel a noticeably larger distance with each breath, and the pattern changes if the person sighs, coughs or drifts into a shallower rhythm while relaxing on the table.

The heartbeat adds a small, fast tremor to anything nearby. The bowel shifts as gas and contents move through it. The bladder fills during a session, nudging the prostate and rectum. Even a well-behaved patient settles into the mattress over half an hour, and a few millimeters of slump is enough to matter when the beam edge is designed to fall off sharply.

Radiation oncologists divide this motion into two categories. Interfraction motion is the difference between where the tumor sat on the planning scan and where it sits on the day of treatment, days or weeks later. Intrafraction motion is the movement that happens during a single session. Conventional image-guided radiotherapy does well with the first kind, by imaging at the start of each visit. The second kind is where continuous or near-continuous tracking earns its keep.

The Mayo Clinic notes that because SRS delivers high doses in few sessions, precise targeting is essential; there is little room to average out errors over many small treatments. That is the practical reason motion management sits at the heart of this technology rather than as an optional extra.

The robotic arm: a linear accelerator that comes to the tumor

Most radiotherapy machines rotate around a single point in a circle, like a wheel around an axle. The patient is positioned so the tumor sits at the hub, and the beam sweeps around it. It is a reliable design, but the geometry is fixed.

The robotic design replaces the wheel with an industrial arm, the kind used to weld car bodies, adapted and shielded for medical use. The linear accelerator on its wrist is small enough that the arm can park it at a large number of pre-defined points in space, called nodes, arranged in a shell around the patient. From each node it can angle the beam in several directions. The result is a treatment plan made up of a great many thin beams converging from above, below, in front and behind, most of them not sharing the same path through healthy tissue.

Why does that help with tracking? Two reasons. Because the arm is not locked to a circular orbit, it can make small corrections in six directions at once: three shifts (up and down, left and right, head to toe) and three rotations (pitch, roll and yaw). A tumor that has tilted slightly since the planning scan can be followed without moving the patient. And because the machine pauses between beams anyway, there is a natural moment for the imaging system to check position and send a correction.

The arm’s job is therefore not to chase the tumor in a dramatic sweep but to make many quiet, small adjustments. The beam itself is only on for short bursts; the arm spends most of the session repositioning. Patients often describe the experience as watching a very patient robot think.

According to MedlinePlus, a session can last from about 30 minutes to roughly two hours depending on the plan, and a full course is usually completed in one to five visits.

Real-time imaging: two X-ray cameras and a reference map

The eyes of the system are a pair of ordinary-looking diagnostic X-ray tubes fixed to the ceiling, aimed at detectors set into the floor on either side of the couch. Because they view the patient from two different angles at the same moment, the software can work out position in three dimensions, the same way two eyes give a person depth perception.

Before treatment, the planning CT scan is used to generate digitally reconstructed radiographs, or DRRs. A DRR is a computer-simulated X-ray showing what the patient should look like from exactly the angle of each ceiling camera if the tumor is precisely where the plan expects it. During the session, each real image pair is compared with its DRR. Any mismatch is translated into a correction vector, a set of numbers telling the arm how far and in which direction to adjust.

How often does this happen? The interval is set by the team for each plan, commonly every few beams or every set number of seconds. More frequent imaging means tighter tracking but slightly more low-dose imaging exposure; the physicist balances the two. If the mismatch is larger than a pre-set tolerance, the system pauses and the therapists reposition the patient before continuing. A large, sudden move, say a cough that shifts the whole torso, triggers a hold rather than a chase.

This is what people mean when they say the imaging is real-time. Strictly, it is near-real-time: a series of snapshots taken frequently enough that the tumor cannot wander far between them. The continuous element comes from the breathing model described later, which fills in the gaps between snapshots.

What the cameras look for depends on the target. In the skull they read bone. In the spine they read vertebrae. In soft organs they usually need help, which is where implanted markers come in.

Skull and spine tracking: using bone as the landmark

For a brain lesion, the tracking problem is nearly solved by anatomy. The skull is rigid and the brain inside it does not slosh around in any way that matters at this scale. The imaging system matches the outline and internal texture of the skull bones in each X-ray pair against the DRRs, calculates any shift or rotation, and corrects. No frame screwed into the scalp is needed; a custom-molded thermoplastic mask holds the head comfortably still and reduces the size of corrections, but it is not the source of accuracy. The cameras are.

This is a genuine difference from the original frame-based radiosurgery of the mid-twentieth century, in which a metal ring was fixed to the skull under local anesthetic so that coordinates could be measured mechanically. The Mayo Clinic describes both frame-based and frameless approaches as established forms of SRS; the frameless version trades the physical fixation for image guidance.

The spine is a subtler case. Vertebrae are bone, so they show up clearly, but the spine is a chain of separate bones that can flex slightly between the planning scan and treatment. Spine tracking software therefore examines a region of interest around the treated level, looking at the pattern of the nearby vertebrae rather than a single bone, and calculates a local correction. This matters because the spinal cord runs a few millimeters from many spinal tumors, and the whole purpose of the technique is to keep the steep edge of the dose on the correct side of that boundary.

In both settings the patient lies still but is not clamped, can breathe normally, and can speak to the therapists through an intercom. If something feels wrong, treatment stops. Patients sometimes worry that scratching an itch will ruin the plan; in practice, the imaging catches the move and the team simply re-aligns.

CyberKnife fiducial markers: when the tumor needs its own beacons

Soft tissue is nearly invisible on a plain X-ray. A lung tumor with good contrast against air may be visible enough to track directly, but a lesion in the liver, pancreas or prostate looks like everything around it. The imaging system needs something to lock onto.

Fiducial markers are the answer. A fiducial is a tiny inert marker, typically made of gold and roughly the size of a grain of rice, placed in or immediately next to the tumor so that it shows up brightly on X-ray. Because gold is dense and does not react with tissue, the markers stay put and stay visible. The imaging software finds each marker in both camera views, triangulates its position, and infers where the tumor is from the fixed relationship between the markers and the target recorded on the planning scan.

Placement is a separate short procedure, usually done under imaging guidance with a needle through the skin, or during a bronchoscopy or endoscopy for some lung and pancreatic tumors. MedlinePlus notes that markers are placed some days before the planning scan so they can settle and so any swelling from placement resolves; the treating team sets the exact interval.

Several markers are generally used rather than one, so that rotation as well as shift can be measured and so that if one migrates or cannot be seen, tracking can continue. Migration is uncommon but does happen, particularly in the lung, and it is one reason the team checks marker positions on the planning CT rather than relying on where they were meant to go.

Not everyone needs fiducials. Bone-based tracking covers the skull and spine, and some lung tumors can be tracked directly against the lung background without any marker. Whether a marker procedure is worthwhile, and its small risks of bleeding, infection or, in the lung, a collapsed lung, is a decision for the radiation oncologist and the doctor performing the placement.

CyberKnife respiratory tracking: following the breath between images

X-ray snapshots every few beams are enough for a target that only drifts slowly. A lung tumor moving with every breath is a different animal; it can travel and return in the time between two images. Respiratory tracking solves this by adding a second, continuous signal and a model linking the two.

The patient wears a snug vest fitted with a few small light-emitting markers over the chest and upper abdomen. A camera at the foot of the couch watches those lights many times per second. Their rise and fall is an external surrogate for breathing, a stand-in signal that is easy to measure continuously but is not the tumor itself.

At the start of the session, the system takes a series of X-ray image pairs at different points in the breathing cycle, each time noting the position of the fiducials or the tumor and, simultaneously, the position of the chest lights. From these paired observations it builds a correlation model: a mathematical description of where the tumor is for any given position of the chest. Once the model exists, the arm can move the beam in step with the lights, in effect following the tumor through each breath even though it is only seeing the tumor directly every so often.

The model is not trusted blindly. Each new X-ray pair checks the prediction against reality; if the two disagree by more than the allowed tolerance, the model is updated or the session pauses. Breathing changes as people relax, and the software is designed to expect that.

There is a small engineering wrinkle worth knowing about. A heavy robotic arm cannot respond instantly, so the system also predicts a fraction of a second ahead to compensate for its own lag. That prediction is what allows the beam to stay centered rather than always arriving slightly late.

For the patient, the experience is unremarkable: breathe normally, do not hold your breath, do not try to help. Trying to breathe evenly usually makes the pattern less regular, not more.

What actually happens on a treatment day

The choreography is more relaxed than most people picture, largely because so much of the work was done before they arrived.

Preparation happens over several visits. If fiducials are needed, they are placed first. Then comes simulation: a planning CT scan, sometimes with additional MRI or PET images fused onto it, taken with the patient in the exact position and immobilization device that will be used for treatment. For head and neck targets that means the custom mask; for body targets it may be a molded cushion that hardens to the person’s shape. Over the following days the radiation oncologist outlines the tumor and the organs that must be protected, and a medical physicist and dosimetrist build the plan, choosing which of the many possible beam paths to use and checking the dose to every nearby structure. NHS guidance on radiotherapy describes this planning stage as routine for any focused radiation treatment.

On the day itself, the therapists settle the patient into the same mask or cushion, fit the breathing vest if needed, and take the first X-ray images to align everything. The lights dim; the arm begins its slow tour. Patients hear the hum of the accelerator during each beam and the soft whir of the arm moving between nodes. There is no sensation from the radiation. Music is often allowed. The team watches from an adjacent room on cameras and can talk through an intercom at any moment.

Between beams the ceiling cameras fire, the screen behind the glass shows the match, and the arm corrects. If a large movement is detected, treatment pauses until the patient is realigned. Most people are on the table for somewhere between half an hour and two hours, as MedlinePlus outlines, and walk out afterwards.

The course is short, typically one to five sessions on consecutive or alternating days, rather than the weeks of daily visits familiar from conventional radiotherapy.

Who robotic radiosurgery is usually for, and who is usually asked to wait

The decision to offer any form of SRS is made by a multidisciplinary team, and the deciding factors are more about the tumor than the machine.

The Mayo Clinic lists common uses of SRS that include brain metastases, certain benign brain tumors such as meningiomas and acoustic neuromas, arteriovenous malformations, trigeminal neuralgia, and, when the same principle is applied to the body as stereotactic body radiotherapy, selected tumors of the lung, liver, spine, pancreas and prostate. Motion tracking becomes particularly relevant for the last group.

Features that tend to make someone a candidate include a target that is small and well defined on imaging, a limited number of lesions, and a location where nearby healthy tissue would be difficult to spare with broader-field radiation or where surgery carries high risk. People who cannot undergo anesthesia, or who prefer to avoid an operation, are often referred for consideration.

Others are usually asked to wait, or are steered toward a different approach. A very large tumor may not be suitable because the high per-session dose cannot be confined safely. Widespread disease across many organs is generally treated systemically rather than spot by spot. Someone who has already had substantial radiation to the same area needs careful assessment of cumulative dose. And a person who cannot lie reasonably still for the session, whether because of pain, breathlessness or restlessness, may need those problems addressed first; tracking corrects small drifts, not constant large movements.

Timing also matters. Fiducial placement, planning scans and plan preparation take days to a couple of weeks, so treatment is not usually immediate. Where a tumor is pressing on the spinal cord or causing acute symptoms, surgery or conventional urgent radiotherapy may be chosen instead because they can begin sooner.

None of this is a checklist a patient can apply to themselves. It is the raw material of a conversation with the treating team.

CyberKnife vs Gamma Knife vs conventional radiotherapy: how the approaches differ

People often arrive having read that one machine is simply better than another. The honest answer is that they are different tools shaped for different jobs, and the choice depends on where the tumor is, how big it is, and what expertise a center has.

Feature	Robotic arm SRS	Frame-based cobalt SRS	Conventional image-guided radiotherapy
Radiation source	Compact linear accelerator on a robotic arm	Many fixed cobalt sources focused on one point	Linear accelerator rotating on a gantry
Immobilization	Mask or body cushion; no frame	Metal frame fixed to the skull (frameless masks now exist for some systems)	Mask or cushion
Motion tracking during treatment	Repeated X-ray imaging plus breathing correlation model	Not needed; head is fixed and target is intracranial	Imaging at start of session; some systems add gating or surface tracking
Typical sites	Brain, spine, lung, liver, pancreas, prostate	Brain and upper cervical spine	Almost any site
Usual course length	1–5 sessions	Usually 1 session	Several weeks of daily sessions

A few points of interpretation. Frame-based radiosurgery, the approach MedlinePlus describes for Gamma Knife, is a mature and well-studied technique for brain targets; its limitation is anatomical rather than technical, because it is designed around the skull. Robotic SRS extends the same dose principle below the neck, which is why motion tracking is central to its design. Conventional fractionated radiotherapy spreads dose over many small sessions, which is gentler on normal tissue within the field and remains the standard for many cancers where a large region, including lymph node areas, needs treatment.

Modern gantry-based accelerators can also deliver stereotactic doses with sophisticated image guidance, and many centers achieve comparable precision with them. Which platform is used for a given patient is a clinical and practical judgment, not a ranking.

How quickly do tumors respond to radiation? The days and weeks after

Radiation does not vaporize a tumor on the spot. It damages the DNA of cells so that they fail when they next try to divide, and it injures the small blood vessels that feed the tumor. Both processes unfold over time, which is why the scan the week after treatment often looks almost unchanged and why the first meaningful follow-up imaging is usually scheduled months rather than days later.

The first few days are typically quiet. The Mayo Clinic describes fatigue and, for brain treatment, mild headache or nausea as the more common short-term effects; some people notice skin redness or tenderness where beams entered, and those with lung treatment may develop a cough over the following weeks. Brain targets can swell temporarily as they respond, which is why a short course of steroid medication is sometimes prescribed by the treating doctor to control swelling; that decision, and its duration, sits entirely with the prescribing clinician.

Over the following weeks and months, different tumors behave differently. Fast-dividing tumors tend to shrink sooner because their cells hit the damaged-DNA checkpoint quickly. Slow-growing benign lesions such as meningiomas or acoustic neuromas may stop growing rather than shrink, and radiologists judge response by stability over successive scans. Arteriovenous malformations close off gradually over a period that can extend to a couple of years, according to the same source.

Follow-up imaging carries its own trap. Treated tissue can look larger or more enhancing on MRI for a while as it undergoes radiation-related change, a picture called pseudoprogression that mimics regrowth. Experienced teams expect this and interpret early scans cautiously, sometimes repeating them rather than acting on a single result.

Practically, most people return to ordinary activity within a day or two, keep any regular medicines as prescribed, and attend the follow-up visits the team schedules. Recovery is measured in how you feel, not in a number on a screen.

What is the downside of CyberKnife? Risks, limits and honest caveats

Every treatment has a cost in risk, and the fact that this one is painless and needle-free can make it sound risk-free. It is not.

The most fundamental limit is that tracking only works on what can be seen. Microscopic spread beyond the visible tumor, and tumors too small or too faint to define on imaging, are outside the beam by design. This is why SRS is generally reserved for discrete, well-mapped targets and why it is often combined with systemic therapy rather than replacing it.

The high dose per session that makes short courses possible also means that the tissue inside the target volume, healthy or not, receives a substantial dose. Radiation necrosis, a patch of dead tissue that can swell and cause symptoms months after brain treatment, is a recognized late effect described by the Mayo Clinic. Near the spinal cord, bowel, airways or major vessels, the margin for error is small, and centers set strict dose limits for those structures.

Fiducial placement carries the small procedural risks of any needle through skin or organ: bleeding, infection, and for lung markers a collapsed lung that may need a chest drain. Marker migration can compromise tracking and occasionally requires replacement. Repeated imaging during treatment adds a modest extra radiation exposure, which the team accounts for in the plan.

Then there are practical downsides. The pathway takes longer to set up than a single urgent radiotherapy session. Treatment sessions themselves are long, which can be hard for someone in pain or short of breath. Not every hospital has the equipment or the experience, and the technique cannot treat the multiple broad fields that many cancers require.

Finally, the honest caveat: comparative evidence between platforms is limited, and most published outcome data concern the principle of stereotactic treatment rather than one manufacturer’s machine. Claims that a specific brand is uniquely effective should be treated with the same skepticism as any other marketing.

What people often get wrong about tracking, success rates and stage 4 cancer

Certain misunderstandings come up in almost every clinic conversation, and correcting them early makes the rest of the discussion easier.

The first is that the word knife means surgery. Nothing is cut. The name is a metaphor for the sharp edge of the dose distribution; there is no incision, no anesthesia and no stitches. Conversely, painless does not mean effect-free: tissue changes, fatigue and swelling can follow, as any radiation oncologist will explain.

The second is the search for a single success rate. People ask, quite reasonably, what percentage of tumors this machine controls. The question does not have a meaningful answer at the level of the machine, because outcomes depend overwhelmingly on the type of tumor, its size, its location, prior treatment and the person’s overall health. A small brain metastasis, a benign meningioma and a pancreatic cancer are entirely different situations that happen to share a delivery platform. The treating team can discuss the evidence for a specific diagnosis; any blanket figure attached to the brand should be disregarded.

The third is that stage 4 means the option is off the table. Stage 4 describes spread beyond the original site, and focused radiation is sometimes used in that setting: to control a limited number of metastases in what oncologists call oligometastatic disease, or to relieve pain or pressure from a single troublesome lesion, alongside systemic treatment. Whether that is appropriate depends on the whole picture, and it is a conversation with the oncology team, not a yes or no attached to a stage number.

The fourth is that tracking chases the tumor continuously with the beam on. In reality the beam is delivered in short pulses between position checks, with the breathing model bridging the gaps for moving targets. The precision comes from measurement and correction, not from a constantly moving spotlight.

The fifth is that a scan a few weeks later will show the result. As the previous section explained, response is judged over months, and early images can mislead in both directions.

Questions to ask your care team before robotic radiosurgery

A good consultation leaves you understanding not just what will happen but why this option was chosen over others. These questions tend to open that conversation.

• Which tracking method will be used for my tumor, bone, marker or direct imaging, and does that mean a separate marker placement procedure?
• How will breathing motion be handled, and is there anything I should practice or avoid before the session?
• How many sessions are planned, how long is each likely to last, and why was that schedule chosen for my case?
• Which healthy structures are closest to the target, and what dose limits are you working to for them?
• What are the alternatives for my situation, including surgery, conventional radiotherapy or systemic treatment, and why is this the recommendation?
• What side effects should I expect in the first two weeks, and which later effects should I watch for over the following months?
• When will the first follow-up scan be, and how will you tell treatment-related change from regrowth?
• Should any of my regular medicines be adjusted around the treatment, and who will make that decision?
• Who do I call, day or night, if something worries me after a session?

Bring someone with you if you can, and ask whether the department has written information or a patient liaison who can answer follow-up questions between visits. It is entirely reasonable to ask how many patients the team treats with this technique each year and how the plan is checked before delivery; quality assurance is a normal part of radiotherapy and departments expect to be asked. Johns Hopkins Medicine describes the multidisciplinary planning that precedes SRS, and understanding who sits on that team helps you know whom to direct each question to.

Write your questions down beforehand. Clinic time is short, and the most useful questions are often the ones that felt too small to ask.

When to call your doctor

Most people feel tired but otherwise well after a session and need nothing more than rest. A small number develop problems that should not wait for the next scheduled appointment.

Call the treatment team or seek urgent care the same day if you notice any of the following after brain or spine treatment: a severe or rapidly worsening headache, especially with vomiting; new weakness, numbness or clumsiness in an arm or leg; new difficulty speaking, understanding or seeing; a seizure; sudden confusion or unusual drowsiness; or new problems controlling bladder or bowel after spinal treatment. These can indicate swelling or pressure on the brain or spinal cord and need prompt assessment, as the Mayo Clinic and NHS both advise for radiotherapy side effects.

After lung or abdominal treatment, or after fiducial marker placement, contact the team if you develop sudden shortness of breath or sharp chest pain, which can signal a collapsed lung; cough up blood; have a fever with chills; notice spreading redness, warmth or pus at a needle site; or have severe abdominal pain, black or bloody stools, or vomiting that will not settle.

Any severe pain that is not controlled by what you have been prescribed, or any symptom that frightens you, is reason enough to call. Departments would far rather hear about a false alarm than miss a real one. Keep the number you were given in your phone and by the bed, and if you cannot reach the team, use local emergency services.

Steroid or anti-nausea medicines, if prescribed, should be taken exactly as the prescribing clinician directed and not stopped early on your own; if side effects from those medicines trouble you, that too is a call to the team rather than a decision to make alone.

Frequently asked questions

How does CyberKnife track tumor movement during breathing?

It combines a continuous external signal with periodic internal confirmation. Light-emitting markers on a vest track the chest wall many times a second, while paired X-ray images taken at intervals locate the tumor or its fiducial markers directly. Software builds a model linking the two, so the robotic arm can follow the predicted tumor position between images, and each new X-ray pair checks and corrects that model.

What is the downside of CyberKnife?

The main limits are that it can only target what imaging can see, that the high per-session dose can injure tissue inside and immediately around the target, and that setup takes longer than conventional urgent radiotherapy. Fiducial placement carries small procedural risks such as bleeding or a collapsed lung. Late effects such as radiation necrosis are recognized. It is not suitable for large tumors or widespread disease needing broad fields.

What is the success rate of CyberKnife?

There is no single meaningful figure, because outcomes depend on tumor type, size, location, prior treatment and overall health rather than on the machine. A benign meningioma, a small brain metastasis and a pancreatic cancer are very different situations that share a delivery platform. Your treating team can discuss the published evidence for your specific diagnosis; any blanket percentage attached to a brand name should be viewed skeptically.

How quickly do tumors respond to radiation?

Response is measured in weeks to months, not days. Radiation damages tumor DNA so cells fail when they next divide, and it injures the tumor’s blood supply; both take time. Fast-growing tumors tend to shrink sooner, slow-growing benign lesions often simply stop growing, and vascular malformations may take up to a couple of years to close. Early scans can show temporary swelling that mimics regrowth, so teams interpret them cautiously.

Can CyberKnife treat stage 4 cancer?

Focused radiation is sometimes used in stage 4 disease, usually to control a limited number of metastases or to relieve pain or pressure from a single lesion, alongside systemic therapy. It does not treat widespread disease across many organs, which is managed with drugs. Whether it is appropriate depends on the number and location of lesions, symptoms and overall health, and that decision rests with the oncology team.

Why are CyberKnife fiducial markers needed for some tumors?

Soft-tissue organs such as the liver, pancreas and prostate are nearly invisible on plain X-ray, so the tracking cameras have nothing to lock onto. Fiducials are rice-grain-sized inert gold markers placed in or beside the tumor that show up brightly, letting software triangulate tumor position from their known relationship to the target. Bone-tracked sites like the skull and spine, and some lung tumors, do not need them.

What is the difference between CyberKnife vs Gamma Knife?

Both deliver high-dose stereotactic radiation in few sessions, but the geometry differs. Frame-based cobalt systems focus many fixed sources on one point and are designed for brain and upper spine targets, traditionally with a frame fixed to the skull. The robotic linear accelerator uses a mask instead of a frame, adds real-time imaging and breathing tracking, and can treat tumors below the neck. Choice depends on site, size and center expertise.

Do I have to hold my breath during CyberKnife respiratory tracking?

No. The system is designed around normal, relaxed breathing. The vest markers record your natural rhythm and the software models where the tumor sits at each point in the cycle. Trying to breathe evenly or hold your breath usually makes the pattern less regular and can trigger pauses. If you have a cough or breathlessness that makes lying still hard, tell the team beforehand so it can be managed.

How long does a CyberKnife session take and how many are needed?

MedlinePlus describes sessions lasting roughly 30 minutes to two hours, depending on the number of beams and how often imaging checks are set, with a full course usually completed in one to five visits. Much of the time on the table is the arm repositioning between short beam deliveries. Planning, and fiducial placement if needed, happen over separate visits in the days or weeks beforehand.

What happens if I move or cough during treatment?

The imaging system detects the shift at the next position check. Small drifts are corrected by re-aiming the robotic arm. A larger movement beyond the set tolerance pauses the beam automatically, and the therapists, who watch from an adjacent room and can talk to you by intercom, realign you before continuing. Movement does not ruin the plan; it simply adds a short pause to the session.

References

• MedlinePlus: Stereotactic radiosurgery – CyberKnife
• MedlinePlus: Stereotactic radiosurgery – Gamma Knife
• NHS: Radiotherapy

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.